Review



recombinant human sclerostin sost  (R&D Systems)


Bioz Verified Symbol R&D Systems is a verified supplier
Bioz Manufacturer Symbol R&D Systems manufactures this product  
  • Logo
  • About
  • News
  • Press Release
  • Team
  • Advisors
  • Partners
  • Contact
  • Bioz Stars
  • Bioz vStars
  • 94

    Structured Review

    R&D Systems recombinant human sclerostin sost
    Recombinant Human Sclerostin Sost, supplied by R&D Systems, used in various techniques. Bioz Stars score: 94/100, based on 41 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/recombinant human sclerostin sost/product/R&D Systems
    Average 94 stars, based on 41 article reviews
    recombinant human sclerostin sost - by Bioz Stars, 2026-02
    94/100 stars

    Images



    Similar Products

    94
    R&D Systems recombinant human sclerostin sost
    Recombinant Human Sclerostin Sost, supplied by R&D Systems, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/recombinant human sclerostin sost/product/R&D Systems
    Average 94 stars, based on 1 article reviews
    recombinant human sclerostin sost - by Bioz Stars, 2026-02
    94/100 stars
      Buy from Supplier

    90
    ACROBiosystems recombinant human sclerostin hst-h5245
    Recombinant Human Sclerostin Hst H5245, supplied by ACROBiosystems, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/recombinant human sclerostin hst-h5245/product/ACROBiosystems
    Average 90 stars, based on 1 article reviews
    recombinant human sclerostin hst-h5245 - by Bioz Stars, 2026-02
    90/100 stars
      Buy from Supplier

    90
    PeproTech recombinant human sclerostin
    Recombinant Human Sclerostin, supplied by PeproTech, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/recombinant human sclerostin/product/PeproTech
    Average 90 stars, based on 1 article reviews
    recombinant human sclerostin - by Bioz Stars, 2026-02
    90/100 stars
      Buy from Supplier

    90
    Thermo Fisher recombinant human sclerostin protein 100–49-1mg
    Recombinant Human Sclerostin Protein 100–49 1mg, supplied by Thermo Fisher, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/recombinant human sclerostin protein 100–49-1mg/product/Thermo Fisher
    Average 90 stars, based on 1 article reviews
    recombinant human sclerostin protein 100–49-1mg - by Bioz Stars, 2026-02
    90/100 stars
      Buy from Supplier

    94
    R&D Systems sclerostin
    Sclerostin, supplied by R&D Systems, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/sclerostin/product/R&D Systems
    Average 94 stars, based on 1 article reviews
    sclerostin - by Bioz Stars, 2026-02
    94/100 stars
      Buy from Supplier

    90
    PeproTech recombinant human (rh)-sclerostin 100-49
    Recombinant Human (Rh) Sclerostin 100 49, supplied by PeproTech, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/recombinant human (rh)-sclerostin 100-49/product/PeproTech
    Average 90 stars, based on 1 article reviews
    recombinant human (rh)-sclerostin 100-49 - by Bioz Stars, 2026-02
    90/100 stars
      Buy from Supplier

    90
    PeproTech recombinant human (rh)-sclerostin
    Primer sequences.
    Recombinant Human (Rh) Sclerostin, supplied by PeproTech, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/recombinant human (rh)-sclerostin/product/PeproTech
    Average 90 stars, based on 1 article reviews
    recombinant human (rh)-sclerostin - by Bioz Stars, 2026-02
    90/100 stars
      Buy from Supplier

    Image Search Results


    Primer sequences.

    Journal: Cells

    Article Title: Sclerostin Alters Tumor Cell Characteristics of Oral Squamous Cell Carcinoma and May Be a Key Player in Local Bone Invasion

    doi: 10.3390/cells13020137

    Figure Lengend Snippet: Primer sequences.

    Article Snippet: The assay was performed according to the manufacturer’s instructions and the luciferase reaction was measured every 24 h. To analyze the influence of recombinant human (rh)-sclerostin (100-49, Peprotech, Hamburg, Germany) on cell proliferation, 1500 cells were seeded per well of a 96-well plate and four different concentrations of sclerostin (0; 1; 5; 10 ng/mL) were tested.

    Techniques: Sequencing

    Clinical patient characteristics and H-score values derived from semiquantitative immunohistochemical evaluation of  sclerostin  expression at the OSCC–jawbone interface. pT indicates the extent of primary OSCC (pT2: tumor extent ≤2 cm with depth of invasion >5 mm and ≤10 mm; or tumor extent >2 cm and ≤4 cm with depth of invasion ≤10 mm; pT3: tumor extent >2 cm and ≤4 cm with depth of invasion >10 mm; or tumor extension >4 cm with depth of invasion ≤10 mm; pT4a: tumor extension >4 cm with depth of invasion >10 mm; or tumor invades adjacent structures (e.g., through the cortical bone of the mandible or maxilla). pN indicates cervical lymph node metastasis (pN0: no lymph node metastasis; pN2b: metastasis in multiple ipsilateral nodes, none >6 cm in largest dimension, and no extranodal extension. pN2c: metastasis in bilateral or contralateral lymph nodes, none >6 cm in largest dimension, and no extranodal extension; pN3b: metastasis in one or more nodes and clinically evident extranodal extension). pM indicates distant metastases (pM0: no distant metastases). H-score values range from 0 to 300, with 0 indicating that no cells are positive and 300 indicating that all cells are strongly positive.

    Journal: Cells

    Article Title: Sclerostin Alters Tumor Cell Characteristics of Oral Squamous Cell Carcinoma and May Be a Key Player in Local Bone Invasion

    doi: 10.3390/cells13020137

    Figure Lengend Snippet: Clinical patient characteristics and H-score values derived from semiquantitative immunohistochemical evaluation of sclerostin expression at the OSCC–jawbone interface. pT indicates the extent of primary OSCC (pT2: tumor extent ≤2 cm with depth of invasion >5 mm and ≤10 mm; or tumor extent >2 cm and ≤4 cm with depth of invasion ≤10 mm; pT3: tumor extent >2 cm and ≤4 cm with depth of invasion >10 mm; or tumor extension >4 cm with depth of invasion ≤10 mm; pT4a: tumor extension >4 cm with depth of invasion >10 mm; or tumor invades adjacent structures (e.g., through the cortical bone of the mandible or maxilla). pN indicates cervical lymph node metastasis (pN0: no lymph node metastasis; pN2b: metastasis in multiple ipsilateral nodes, none >6 cm in largest dimension, and no extranodal extension. pN2c: metastasis in bilateral or contralateral lymph nodes, none >6 cm in largest dimension, and no extranodal extension; pN3b: metastasis in one or more nodes and clinically evident extranodal extension). pM indicates distant metastases (pM0: no distant metastases). H-score values range from 0 to 300, with 0 indicating that no cells are positive and 300 indicating that all cells are strongly positive.

    Article Snippet: The assay was performed according to the manufacturer’s instructions and the luciferase reaction was measured every 24 h. To analyze the influence of recombinant human (rh)-sclerostin (100-49, Peprotech, Hamburg, Germany) on cell proliferation, 1500 cells were seeded per well of a 96-well plate and four different concentrations of sclerostin (0; 1; 5; 10 ng/mL) were tested.

    Techniques: Derivative Assay, Immunohistochemistry, Expressing

    Immunohistochemical staining protocol.

    Journal: Cells

    Article Title: Sclerostin Alters Tumor Cell Characteristics of Oral Squamous Cell Carcinoma and May Be a Key Player in Local Bone Invasion

    doi: 10.3390/cells13020137

    Figure Lengend Snippet: Immunohistochemical staining protocol.

    Article Snippet: The assay was performed according to the manufacturer’s instructions and the luciferase reaction was measured every 24 h. To analyze the influence of recombinant human (rh)-sclerostin (100-49, Peprotech, Hamburg, Germany) on cell proliferation, 1500 cells were seeded per well of a 96-well plate and four different concentrations of sclerostin (0; 1; 5; 10 ng/mL) were tested.

    Techniques: Immunohistochemistry, Staining

    Graphical representation of the averaged delta CT values from the qRT-PCR experiments for the two different OSCC tumor cell lines (SCC-040 and PCI-13). Higher CT values indicate low sclerostin expression, while lower values indicate higher expression. For normalization, the delta CT value was calculated with the CT values of GAPDH and sclerostin (SOST) from each cell line. SCC-040 tumor cells have higher sclerostin expression than PCI-13 tumor cells.

    Journal: Cells

    Article Title: Sclerostin Alters Tumor Cell Characteristics of Oral Squamous Cell Carcinoma and May Be a Key Player in Local Bone Invasion

    doi: 10.3390/cells13020137

    Figure Lengend Snippet: Graphical representation of the averaged delta CT values from the qRT-PCR experiments for the two different OSCC tumor cell lines (SCC-040 and PCI-13). Higher CT values indicate low sclerostin expression, while lower values indicate higher expression. For normalization, the delta CT value was calculated with the CT values of GAPDH and sclerostin (SOST) from each cell line. SCC-040 tumor cells have higher sclerostin expression than PCI-13 tumor cells.

    Article Snippet: The assay was performed according to the manufacturer’s instructions and the luciferase reaction was measured every 24 h. To analyze the influence of recombinant human (rh)-sclerostin (100-49, Peprotech, Hamburg, Germany) on cell proliferation, 1500 cells were seeded per well of a 96-well plate and four different concentrations of sclerostin (0; 1; 5; 10 ng/mL) were tested.

    Techniques: Quantitative RT-PCR, Expressing

    Graphical representation of the relative mRNA expression from the qRT-PCR experiments for the different osteogenesis markers ALPL, COL1A1, osteocalcin, osteopontin, osterix, and Runx2, as well as sclerostin expression. Undifferentiated hMSCs served as controls, GAPDH was used as internal housekeeping gene. Successful osteogenic differentiation of hMSCs is shown.

    Journal: Cells

    Article Title: Sclerostin Alters Tumor Cell Characteristics of Oral Squamous Cell Carcinoma and May Be a Key Player in Local Bone Invasion

    doi: 10.3390/cells13020137

    Figure Lengend Snippet: Graphical representation of the relative mRNA expression from the qRT-PCR experiments for the different osteogenesis markers ALPL, COL1A1, osteocalcin, osteopontin, osterix, and Runx2, as well as sclerostin expression. Undifferentiated hMSCs served as controls, GAPDH was used as internal housekeeping gene. Successful osteogenic differentiation of hMSCs is shown.

    Article Snippet: The assay was performed according to the manufacturer’s instructions and the luciferase reaction was measured every 24 h. To analyze the influence of recombinant human (rh)-sclerostin (100-49, Peprotech, Hamburg, Germany) on cell proliferation, 1500 cells were seeded per well of a 96-well plate and four different concentrations of sclerostin (0; 1; 5; 10 ng/mL) were tested.

    Techniques: Expressing, Quantitative RT-PCR

    Illustration of tumor cell proliferation under sclerostin treatment at different concentrations (1, 5, and 10 ng/mL) and time periods (24 h, 36 h, 48 h, 60 h, and 72 h). Untreated tumor cells (0 ng/mL) were used as controls: ( a ) SCC-040 cell line; ( b ) PCI-13 cell line. Statistical test: one-way ANOVA with Tukey’s tests for post hoc comparisons; * p -values between 0.01 and 0.05 (significant); ** p -values between 0.001 and 0.01 (very significant). A significant influence of sclerostin on the tumor cell proliferation rate is shown, which seems to be time- and dose-dependent.

    Journal: Cells

    Article Title: Sclerostin Alters Tumor Cell Characteristics of Oral Squamous Cell Carcinoma and May Be a Key Player in Local Bone Invasion

    doi: 10.3390/cells13020137

    Figure Lengend Snippet: Illustration of tumor cell proliferation under sclerostin treatment at different concentrations (1, 5, and 10 ng/mL) and time periods (24 h, 36 h, 48 h, 60 h, and 72 h). Untreated tumor cells (0 ng/mL) were used as controls: ( a ) SCC-040 cell line; ( b ) PCI-13 cell line. Statistical test: one-way ANOVA with Tukey’s tests for post hoc comparisons; * p -values between 0.01 and 0.05 (significant); ** p -values between 0.001 and 0.01 (very significant). A significant influence of sclerostin on the tumor cell proliferation rate is shown, which seems to be time- and dose-dependent.

    Article Snippet: The assay was performed according to the manufacturer’s instructions and the luciferase reaction was measured every 24 h. To analyze the influence of recombinant human (rh)-sclerostin (100-49, Peprotech, Hamburg, Germany) on cell proliferation, 1500 cells were seeded per well of a 96-well plate and four different concentrations of sclerostin (0; 1; 5; 10 ng/mL) were tested.

    Techniques:

    Illustration of PCI-13 tumor cell migration and invasion after 24 h under sclerostin treatment at different concentrations (1 and 5 ng/mL). Untreated tumor cells (0 ng/mL) were used as controls: ( a ) Migration of PCI-13 tumor cells; ( b ) Invasion of PCI-13 tumor cells. Statistical test: one-way ANOVA with Tukey’s tests for post hoc comparisons; ** p -values between 0.001 and 0.01 (very significant); **** p -values < 0.0001 (extremely significant). A significant effect of sclerostin on tumor cell migration and invasion rate is shown, which seems to be dose-dependent.

    Journal: Cells

    Article Title: Sclerostin Alters Tumor Cell Characteristics of Oral Squamous Cell Carcinoma and May Be a Key Player in Local Bone Invasion

    doi: 10.3390/cells13020137

    Figure Lengend Snippet: Illustration of PCI-13 tumor cell migration and invasion after 24 h under sclerostin treatment at different concentrations (1 and 5 ng/mL). Untreated tumor cells (0 ng/mL) were used as controls: ( a ) Migration of PCI-13 tumor cells; ( b ) Invasion of PCI-13 tumor cells. Statistical test: one-way ANOVA with Tukey’s tests for post hoc comparisons; ** p -values between 0.001 and 0.01 (very significant); **** p -values < 0.0001 (extremely significant). A significant effect of sclerostin on tumor cell migration and invasion rate is shown, which seems to be dose-dependent.

    Article Snippet: The assay was performed according to the manufacturer’s instructions and the luciferase reaction was measured every 24 h. To analyze the influence of recombinant human (rh)-sclerostin (100-49, Peprotech, Hamburg, Germany) on cell proliferation, 1500 cells were seeded per well of a 96-well plate and four different concentrations of sclerostin (0; 1; 5; 10 ng/mL) were tested.

    Techniques: Migration

    Illustration of the scratch assay performed to verify migration characteristics for the PCI-13 OSCC tumor cell line with (1 and 5 ng/mL) and without (0 ng/mL, control) sclerostin treatment. Magnification ×4.

    Journal: Cells

    Article Title: Sclerostin Alters Tumor Cell Characteristics of Oral Squamous Cell Carcinoma and May Be a Key Player in Local Bone Invasion

    doi: 10.3390/cells13020137

    Figure Lengend Snippet: Illustration of the scratch assay performed to verify migration characteristics for the PCI-13 OSCC tumor cell line with (1 and 5 ng/mL) and without (0 ng/mL, control) sclerostin treatment. Magnification ×4.

    Article Snippet: The assay was performed according to the manufacturer’s instructions and the luciferase reaction was measured every 24 h. To analyze the influence of recombinant human (rh)-sclerostin (100-49, Peprotech, Hamburg, Germany) on cell proliferation, 1500 cells were seeded per well of a 96-well plate and four different concentrations of sclerostin (0; 1; 5; 10 ng/mL) were tested.

    Techniques: Wound Healing Assay, Migration

    Illustration of the scratch assay to visualize the migration rate of PCI-13 tumor cells under sclerostin treatment at different concentrations (1 and 5 ng/mL) over different time periods (0 h, 12 h, 24 h, 36 h). No significant effect of sclerostin was observed in the scratch assay.

    Journal: Cells

    Article Title: Sclerostin Alters Tumor Cell Characteristics of Oral Squamous Cell Carcinoma and May Be a Key Player in Local Bone Invasion

    doi: 10.3390/cells13020137

    Figure Lengend Snippet: Illustration of the scratch assay to visualize the migration rate of PCI-13 tumor cells under sclerostin treatment at different concentrations (1 and 5 ng/mL) over different time periods (0 h, 12 h, 24 h, 36 h). No significant effect of sclerostin was observed in the scratch assay.

    Article Snippet: The assay was performed according to the manufacturer’s instructions and the luciferase reaction was measured every 24 h. To analyze the influence of recombinant human (rh)-sclerostin (100-49, Peprotech, Hamburg, Germany) on cell proliferation, 1500 cells were seeded per well of a 96-well plate and four different concentrations of sclerostin (0; 1; 5; 10 ng/mL) were tested.

    Techniques: Wound Healing Assay, Migration

    Histological illustration of the OSCC–jawbone interface with additional sclerostin immunohistochemistry. ( A ) Overview of the boundary between the local jawbone and the surrounding tumor cell clusters of OSCC; ( B ) enlarged view; ( C ) highly magnified image of direct tumor cell–bone contact with osteolysis lacunae; ( D ) visualization of multinucleated osteoclasts within osteolysis lacunae (OL). Significant sclerostin expression was found in both OSCC tumor cells and bone-associated cells at the OSCC–jawbone interface.

    Journal: Cells

    Article Title: Sclerostin Alters Tumor Cell Characteristics of Oral Squamous Cell Carcinoma and May Be a Key Player in Local Bone Invasion

    doi: 10.3390/cells13020137

    Figure Lengend Snippet: Histological illustration of the OSCC–jawbone interface with additional sclerostin immunohistochemistry. ( A ) Overview of the boundary between the local jawbone and the surrounding tumor cell clusters of OSCC; ( B ) enlarged view; ( C ) highly magnified image of direct tumor cell–bone contact with osteolysis lacunae; ( D ) visualization of multinucleated osteoclasts within osteolysis lacunae (OL). Significant sclerostin expression was found in both OSCC tumor cells and bone-associated cells at the OSCC–jawbone interface.

    Article Snippet: The assay was performed according to the manufacturer’s instructions and the luciferase reaction was measured every 24 h. To analyze the influence of recombinant human (rh)-sclerostin (100-49, Peprotech, Hamburg, Germany) on cell proliferation, 1500 cells were seeded per well of a 96-well plate and four different concentrations of sclerostin (0; 1; 5; 10 ng/mL) were tested.

    Techniques: Immunohistochemistry, Expressing